Literature DB >> 8068409

Transmission and pathogenesis of human immunodeficiency virus type 1.

R I Connor1, D D Ho.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8068409     DOI： 10.1089/aid.1994.10.321

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  7 in total

1.  Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.

Authors:  G Alkhatib; C C Broder; E A Berger
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.

Authors:  R Tanaka; A Yoshida; T Murakami; E Baba; J Lichtenfeld; T Omori; T Kimura; N Tsurutani; N Fujii; Z X Wang; S C Peiper; N Yamamoto; Y Tanaka
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice.

Authors:  C Masurier; B Salomon; N Guettari; C Pioche; F Lachapelle; M Guigon; D Klatzmann
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Pillars article: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996. 272: 872-877.

Authors:  Yu Feng; Christopher C Broder; Paul E Kennedy; Edward A Berger
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 5.  DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations.

Authors:  K E Ugen; B Wang; V Ayyavoo; M Agadjanyan; J Boyer; F Li; S Kudchodkar; J Lin; M Merva; L Fernandes
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.

Authors:  C C Broder; E A Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

7.  Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants.

Authors:  J Lewis; P Balfe; C Arnold; S Kaye; R S Tedder; J A McKeating
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.